Toll-like receptor 4 region genetic variants are associated with susceptibility to melioidosis

T E West1, W Chierakul, N Chantratita

  • 1Division of Pulmonary & Critical Care Medicine, Department of Medicine, Harborview Medical Center, University of Washington, Seattle, WA 98104, USA. tewest@u.washington.edu

Genes and Immunity
|July 22, 2011
PubMed

Insights

Genetic variations in Toll-like receptors (TLRs) may influence susceptibility to melioidosis, a tropical bacterial infection. Certain TLR4 and TLR1 gene variants were linked to protection or increased risk of developing the disease.

Area of Science:

  • Immunology
  • Genetics
  • Infectious Diseases

Background:

  • Melioidosis, caused by Burkholderia pseudomallei, is prevalent in tropical regions like northeastern Thailand.
  • Host susceptibility mechanisms for melioidosis remain poorly understood, despite diabetes being a known risk factor.

Purpose of the Study:

  • To investigate the association between genetic variations in Toll-like receptors (TLRs) and host susceptibility to melioidosis.
  • To identify specific TLR polymorphisms that correlate with disease development or protection.

Main Methods:

  • Case-control study comparing frequencies of TLR pathway polymorphisms in melioidosis cases and controls (non-hospitalized and hospitalized).
  • Analysis included eight known TLR polymorphisms, followed by investigation of additional TLR4 and TLR6-1-10 region variants.

Main Results:

  • The TLR4(1196C>T) variant showed a protective association against melioidosis compared to non-hospitalized controls.
  • TLR1(742A>G) and TLR1(-7202A>G) variants were associated with increased melioidosis risk compared to hospitalized controls.
  • Additional TLR4 and TLR6-1-10 region polymorphisms were linked to disease, particularly in diabetic patients.

Conclusions:

  • Genetic variants in Toll-like receptors may play a role in modulating host susceptibility to melioidosis.
  • Further research is needed to confirm these findings and elucidate the underlying mechanisms.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...